IP Library Assignment 066542/0579
Patent Assignment
Reel/Frame 066542/0579

Change of Name

Recorded: 2024-02-23 Pages: 2
Assignor
KEMPHARM DENMARK A/S
Executed: 2023-07-05
Assignee
ZEVRA DENMARK A/S
OLE MAALØES VEJ 3, COPENHAGEN N, 2200, DENMARK
Covered Property (1)
Arimoclomol for Treating Glucocerebrosidase Associated Disorders
Application: 16/879,198 →
Publication: US 2020/0289497
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 30, 2020
From: HINSBY, ANDERS MØRKEBERG; JENSEN, THOMAS KIRKEGAARD; FOG-TONNESEN, CATHERINE KOLSTER; PETERSEN, NIKOLAJ HAVNSØE TORP
To: ORPHAZYME A/S
Reel/Frame 053093/0233 →
Assignment of Assignor's Interest Jul 6, 2022
From: KEMPHARM, INC.
To: KEMPHARM DENMARK A/S
Reel/Frame 060592/0595 →
Assignment of Assignor's Interest Jul 6, 2022
From: ORPHAZYME A/S
To: KEMPHARM, INC.
Reel/Frame 060592/0646 →